Get the Stockscreener App
6.01
1.47%
-0.13
Profound Medical Corp stock is traded at $6.01, with a volume of 22,877.
It is down -1.47% in the last 24 hours and down -21.02% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$6.14
Open:
$6.11
24h Volume:
22,877
Relative Volume:
0.29
Market Cap:
$184.37M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-4.4851
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
-6.20%
1M Performance:
-21.02%
6M Performance:
-36.98%
1Y Performance:
-29.32%
1-Day Range:
$5.92
$6.20
1-Week Range:
$5.92
$6.44
52-Week Range:
$5.92
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
-
Address
-
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.06 | 184.37M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
129.06 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.28 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.34 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.59 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.68 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical (TSE:PRN) Hits New 12-Month LowWhat's Next? - MarketBeat
Gagnon Advisors LLC Has $6.73 Million Stock Holdings in Profound Medical Corp. (NASDAQ:PROF) - MarketBeat
Gagnon Securities LLC Raises Holdings in Profound Medical Corp. (NASDAQ:PROF) - MarketBeat
Profound Medical (NASDAQ:PROF) Shares Down 5.3%What's Next? - MarketBeat
Profound Medical (TSE:PRN) Reaches New 1-Year LowHere's Why - MarketBeat
Is beaten down PROF stock a buy now? - Cantech Letter
Interventional Oncology Market to Hit USD 4.24 Billion by 2029 with 9.0% CAGR | MarketsandMarkets - The Malaysian Reserve
Market Sentiment Around Loss-Making Profound Medical Corp. (TSE:PRN) - Simply Wall St
Profound Medical stock hits 52-week low at $6.61 amid market challenges - MSN
GAGNON SECURITIES LLC Acquires Significant Stake in Profound Med - GuruFocus.com
Profound Medical Corp.'s (TSE:PRN) Profit Outlook - Yahoo Finance
Mölnlycke Health Care Appoints New CFO - MPO-mag
(PROF) Long Term Investment Analysis - Stock Traders Daily
Profound Medical Adjusts J.P. Morgan Conference Schedule for Enhanced Visibility - TipRanks
Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th - The Manila Times
Profound Medical Corp. Issues Preliminary Unaudited Revenues Report for Q4 2024 - Defense World
Stocks In Play - Baystreet.ca
Does Profound Medical (PROF) Have the Potential to Rally 100.13% as Wall Street Analysts Expect? - MSN
Onera Health Appoints Maria Sainz as Chair of the Board - Via Ritzau
Stocks In Play: Profound Medical Corp. By Baystreet.ca - Investing.com Canada
Profound Medical Corp (PRN-T) QuotePress Release - The Globe and Mail
Profound Medical Corp. - Baystreet.ca
Profound Medical Corp. Provides Earnings Guidance for the Fourth Quarter and for Full Year of 2024 - Marketscreener.com
Profound Medical reports FY24 revenue above consensus - MSN
Profound Medical Reports Robust Revenue Growth and Transition to U.S. GAAP - TipRanks
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - The Manila Times
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - Benzinga
Profound Medical (TSE:PRN) Stock Price Down 2.2%Time to Sell? - MarketBeat
Profound Medical (TSE:PRN) Shares Down 2.2% – Here’s What Happened - Defense World
How the (PROF) price action is used to our Advantage - Stock Traders Daily
Profound Medical to Present at J.P. Morgan Healthcare Conference - TipRanks
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Key factors to consider when considering risk and progression of BPH - Urology Times
Profound Medical (TSE:PRN) soars 14% this week, taking one-year gains to 18% - Simply Wall St
Profound Medical stock reaffirmed at Buy at Lake Street on favourable setup in 2025 - Investing.com Canada
2024 Urology Times pipeline report - Urology Times
Profound Medical Corp (PRN-T) Profile - The Globe and Mail
Profound Medical stock hits 52-week low at $6.87 amid market challenges - Investing.com
Critical Survey: enVVeno Medical (NASDAQ:NVNO) versus Profound Medical (NASDAQ:PROF) - Defense World
Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry? - Streetwise Reports
Profound Medical (NASDAQ:PROF) versus Westaim (OTCMKTS:WEDXF) Critical Contrast - Defense World
Closing Bell: Profound Medical Corp Down On Thursday (PRN) - Barchart
Profound Medical Successfully Prices Public Offering to Boost Commercialization Efforts - TipRanks
Raymond James Boosts Earnings Estimates for Profound Medical - MarketBeat
Raymond James Has Positive Outlook for PROF FY2024 Earnings - MarketBeat
FY2024 EPS Estimate for Profound Medical Lifted by Analyst - Defense World
FY2024 EPS Forecast for Profound Medical Boosted by Analyst - Defense World
Profound Medical stock hits 52-week low at $7.01 amid market shifts - Investing.com Australia
Profound Medical stock hits 52-week low at $7.01 amid market shifts By Investing.com - Investing.com South Africa
Tumor Ablation Market Share, Opportunities Analysis, Recent Trends, Regional Growth And Outlook By 2033 - WhaTech
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock - Yahoo Finance UK
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):